Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancerHisatsugu Goto, Yasuhiko Nishioka, Takanori Kanematsu et al.|Respiratory Investigation|2017Cited by 13
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancerYuki Tsukazaki, Yasuhiko Nishioka, Hirokazu Ogino et al.|International Journal of Clinical Oncology|2024Cited by 8
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancerHideki Tomimoto, Saburo Sone, Masaki Hanibuchi et al.|Oncology Letters|2011Cited by 3
Interleukin-10 inhibits the production of inflammatory cytokines by antigen-stimulated mononuclear cells from asthmatic patientsToshiya Takahashi, Saburo Sone, Kenichi Maeda et al.|Allergology International|2000Cited by 1
Phase II study of S-1 with patient-reported outcome evaluation in elderly patients with previously untreated advanced non-small cell lung cancerHirokazu Ogino, Yasuhiko Nishioka, Hisatsugu Goto et al.|Lung Cancer|2017Cited by 0